488 results on '"Mikov, M."'
Search Results
2. Antihypertensive drugs in blood donations in Serbia – Observational study
3. The Effects of Primary Unconjugated Bile Acids on Nanoencapsulated Pharmaceutical Formulation of Hydrophilic Drugs: Pharmacological Implications
4. Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells
5. Molecular mechanism of action and pharmacokinetic properties of methotrexate
6. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
7. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
8. Epidemiological Characteristics of Gastric Cancer in Vojvodina
9. Impact of winter savory extract (Satureja montana L.) on biochemical parameters in serum and oxidative status of liver with application of the principal component analysis in extraction solvent selection.
10. Influence of bile acid derivates on tramadol analgesic effect in mice
11. In vivo tumour-suppressive effects of alpha-tocopheryl succinate in Ehrlich ascites carcinoma: TUE-134
12. CLINICAL PHARMACOLOGY VISIBILITY ENHANCEMENT WITHIN HEALTH SYSTEM - THE EXAMPLE OF THE SECTION FOR CLINICAL PHARMACOLOGY SERBIAN MEDICAL SOCIETY: 1075
13. THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS: 561
14. Anthracycline-based combined chemotherapy in the mouse model
15. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3α,7α-dihydroxy-12-0X0-5β-cholanate, in healthy and diabetic rats
16. Chemical and metabolic transformations of selected bile acids
17. Structure and origin of bile acids: An overview
18. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents
19. Isolation and determination of bile acids
20. Biosynthesis of bile acids in mammalian liver
21. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: Study in healthy volunteers
22. Bile acids and probiotics could help treating diabetes: P12-11
23. THE INFLUENCE OF METHYL ESTER OF MONOKETOCHOLIC ACID ON QUININE ENTERING THE CENTRAL NERVOUS SYSTEM IN RATS: P309
24. INTERFERENCE OF BILE ACID DERIVATES WITH MORPHINE ANALGESIC EFFECT: P310
25. USE OF ACE INHIBITORS IN SERBIA COMPARED WITH MONTENEGRO IN 2009: PHARMACOEPIDEMIOLOGY AND PHARMACOECONOMIC ASPECTS: P288
26. HOSPITAL USE OF DRUGS IN UROLOGY CLINIC OF CLINICAL CENTRE OF MONTENEGRO: P283
27. THE USE OF CARDIOVASCULAR MEDICINES IN CENTER OF CARDIOLOGY, CLINICAL CENTER OF MONTENEGRO: P281
28. OUT HOSPITAL USE OF ATC GROUP N DRUGS FUNDED BY HEALTH SERVICE FUND IN MONTENEGRO IN 2009: P276
29. EDUCATION OF CLINICAL PHARMACOLOGY: NEED FOR HARMONIZATION PROCESS?: I72
30. BIOEQUIVALENCE STUDIES - 25 YEAR EXPERIENCE OF NOVI SAD: I51
31. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants
32. CLINICAL PHARMACOLOGY (CP) VS. PHARMACEUTICAL MEDICINE (PM) EXPERIENCE FROM SERBIA: O6
33. Pharmacokinetics of carbamazepine derived from a new tablet formulation
34. The metabolism of drugs by the gut flora
35. Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study
36. An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
37. Ursodeoxycholic acid modulates intracellular redox state and sensitizes colon cancer cells to the cytotoxicity induced by epigenetic agent vorinostat
38. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
39. Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring
40. Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses
41. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
42. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
43. Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
44. Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring
45. The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
46. Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
47. Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
48. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
49. Bile Acid Derivatives as a Promising Metabolic Syndrome Treatment?
50. Counterfeit Drugs as A Common Risk For The Successful Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.